Wolff Stefani
SEC CIK 1751790 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | EVP, COO | 6,113 | — | $22.3K | 10 | 2022-04-30 | 2023-05-01 |
Most active insiders at NRIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ring Christine | CLO | — | $3.26M |
| 2 | van Houte Hans | CFO | — | $635.3K |
| 3 | Hansen Gwenn | CSO | — | $630.9K |
Wolff Stefani made no open-market trades at NRIX in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-02 | 2023-04-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 6,455 | +18% | $0 |
| D | 2023-05-02 | 2023-05-01 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | S - Sale+OE | $9.88 | -342 | 6,113 | -5% | -$3,379 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 4,364 | +28% | $0 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | S - Sale+OE | $11.78 | -424 | 3,940 | -10% | -$4,995 |
| D | 2022-11-01 | 2022-10-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 3,752 | +34% | $0 |
| D | 2022-11-01 | 2022-10-31 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | S - Sale+OE | $12.88 | -350 | 3,402 | -9% | -$4,508 |
| D | 2022-08-02 | 2022-08-01 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | S - Sale+OE | $15.67 | -356 | 1,238 | -22% | -$5,579 |
| D | 2022-08-02 | 2022-07-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 1,594 | +152% | $0 |
| D | 2022-05-03 | 2022-04-30 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 962 | New | $0 |
| D | 2022-05-03 | 2022-05-02 | NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP, COO | S - Sale+OE | $11.75 | -330 | 632 | -34% | -$3,878 |
Purchase Sale Sale after option exercise All abbreviations